2021 CSL Centenary Fellowships Announced

First Patient Enrolled in NIH Phase 3 Trial to Evaluate Potential COVID-19 Hyperimmune Medicine

CSL’s Global Role in Battling COVID-19

Here is how CSL is working around the world with academia, industry and governments to combat the novel coronavirus COVID-19 …

Agreement to supply 51 mil vaccine doses

COVID-19 Update

CSL continues to provide medicines to patients around the world.

Joy Linton named as Chief Financial Officer

CSL has appointed Ms Joy Linton, a well-respected global leader with extensive strategic and financial experience as Chief Fi…

CSL to manufacture and supply vaccine candidates

CSL Media Statement on COVID19 Vaccine Manufacture

Development of the University of Queensland’s vaccine candidate remains CSL’s priority.